论文部分内容阅读
目的:观察舒利迭(沙美特罗/氟替卡松)治疗支气管哮喘的疗效。方法:将确诊支气管哮喘患者38例,分为吸入糖皮质激素和长效β受体激动剂的复方制剂舒利迭(沙美特罗/氟替卡松)治疗组20例;吸入糖皮质激素(丙酸氟替卡松)对照组18例。治疗后对临床疗效、肺功能指标进行比较及统计学分析。结果:舒利迭治疗组用药后临床疗效和肺功能改善方面明显优于对照组。结论:舒利迭在治疗支气管哮喘改善临床症状和肺功能明显,较单纯吸入糖皮质激素能更好控制及改善的哮喘症状。
Objective: To observe the efficacy of seretide (salmeterol / fluticasone) in the treatment of bronchial asthma. Methods: Thirty-eight patients diagnosed with bronchial asthma were randomly divided into two groups: 20 patients receiving salmeterol / salmeterol / fluticasone, inhaled glucocorticoid and long-acting β-agonist; ) Control group of 18 cases. After treatment, the clinical efficacy and pulmonary function indicators were compared and statistically analyzed. Results: Seretide treatment group was significantly better than the control group in clinical efficacy and improvement of pulmonary function after treatment. Conclusion: Seretide in the treatment of bronchial asthma to improve clinical symptoms and lung function significantly better than simple inhaled glucocorticoid can better control and improve asthma symptoms.